# Predicting Response to Immunochemotherapy in Early Triple Negative Breast Cancer

> **NCT07570524** · — · NOT_YET_RECRUITING · sponsor: **Center Eugene Marquis** · enrollment: 200 (estimated)

## Conditions studied

- Triple-negative Breast Cancer (TNBC)

## Interventions

- **BIOLOGICAL:** Additionnal breast biospy and blood sample

## Key facts

- **NCT ID:** NCT07570524
- **Lead sponsor:** Center Eugene Marquis
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-01
- **Primary completion:** 2036-05-31
- **Final completion:** 2036-05-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07570524

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07570524, "Predicting Response to Immunochemotherapy in Early Triple Negative Breast Cancer". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07570524. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*